{"entities":{"Q9818":{"pageid":13979,"ns":120,"title":"Item:Q9818","lastrevid":205739,"modified":"2020-05-21T15:45:17Z","type":"item","id":"Q9818","labels":{"en":{"language":"en","value":"Riechelmann H, et al. Oral. Oncol. (2008) cited as Ref 555 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9818$F96623B1-A71F-4738-9027-1A58B16A1931","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9818$3D46305A-5FE1-446D-907C-B9B7DEE0FE08","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Riechelmann H","type":"string"},"datatype":"string"},"type":"statement","id":"Q9818$EA28C3CD-B0FB-4EC0-AFA3-D5B9A4E9E259","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1016/j.oraloncology.2007.10.009","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9818$5F155751-6DFA-4DF5-981E-55470225ACB4","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"18203652","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9818$D3EA12F0-F65C-45A0-8783-EDD251C196FD","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2008-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9818$40AEF1C6-FDDB-4A9D-B446-18CE038F8166","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Oral. Oncol.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9818$648F6935-1768-4864-81B1-4973B8BDAA28","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"44","type":"string"},"datatype":"string"},"type":"statement","id":"Q9818$79F4E6F6-5123-4DF1-B547-7D8B700C1044","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9818$2918AE46-7C6D-4C64-8766-04CF9E5DC369","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"823-829","type":"string"},"datatype":"string"},"type":"statement","id":"Q9818$EE26E786-1922-4EDE-A901-5926063F9831","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Riechelmann H, et al. Oral. Oncol. (2008) cited as Ref 555 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Riechelmann_H,_et_al._Oral._Oncol._(2008)_cited_as_Ref_555_in_DOI:_10.1038/s41392-020-0110-5"}}}}}